| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Spero Therapeutics, Inc. | Chief Operating Officer | Common Stock | 740K | $1.46M | $1.97 | Aug 28, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SPRO | Spero Therapeutics, Inc. | Aug 28, 2025 | 1 | -$3.34K | 4 | Sep 3, 2025 | Chief Operating Officer |
| SPRO | Spero Therapeutics, Inc. | Feb 3, 2025 | 4 | -$44.1K | 4 | Feb 5, 2025 | Chief Operating Officer |
| SPRO | Spero Therapeutics, Inc. | Aug 27, 2024 | 1 | -$2.99K | 4 | Aug 29, 2024 | Chief Operating Officer |
| SPRO | Spero Therapeutics, Inc. | Feb 1, 2024 | 2 | -$42.1K | 4 | Feb 5, 2024 | Chief Operating Officer |
| SPRO | Spero Therapeutics, Inc. | Aug 28, 2023 | 1 | -$2.34K | 4 | Aug 30, 2023 | Chief Development Officer |
| SPRO | Spero Therapeutics, Inc. | Feb 1, 2023 | 2 | -$6.31K | 4 | Feb 3, 2023 | Chief Operating Officer |
| SPRO | Spero Therapeutics, Inc. | Feb 1, 2022 | 2 | $0 | 4 | Feb 3, 2022 | Chief Development Officer |
| SPRO | Spero Therapeutics, Inc. | Aug 26, 2021 | 1 | $0 | 4 | Aug 30, 2021 | Chief Development Officer |